Allan Oberman serves as Executive at Sagent Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Allan Oberman has executed 5 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 29, 2016 involved selling 92,527 shares valued at $2.0M.
Allan Oberman currently holds 92,527 shares of Sagent Pharmaceuticals, Inc. (SGNT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Allan Oberman has been a net neutral trader of SGNT stock. They have purchased $0 and sold $0 worth of shares.
Allan Oberman's most recent insider trade was on Aug 29, 2016, when they sold 92,527 shares at $21.75 per share.
Get notified when new Form 4 filings are submitted
| 9,459 |
| $21.75 |
| Discretionary |
| Aug 3, 2016 | SGNT | $92.9K | Payment | 4,271 | $21.74 | Discretionary |
| Feb 22, 2016 | SGNT | $0 | Award | 51,335 | $N/A | Discretionary |
| Aug 3, 2015 | SGNT | $0 | Award | 54,922 | $N/A | Discretionary |